• Janet's Message

    Janet's message inspires us all to continue the fight against ovarian cancer. She devoted her heart and soul to the South Carolina Ovarian Cancer Foundation.

  • SCOCF Spokesperson Andie MacDowell

    Andie serves on our Board of Directors and she serves a 'Spokesperson for the South Carolina Ovarian Cancer Foundation'. View our new Awareness Ads here!

  • Donate Now!

    Make a donation to support the SCOCF

OvarianCancer.org

Avastin Approved for Ovarian Cancer

Friday, November 14, 2014- Today, the Food and Drug Administration announced the approval of Genentech’s Avastin (bevacizumab) in combination with chemotherapy for women with platinum-resistant recurrent ovarian cancer. The approval was based on the results of a Phase III clinical trial which showed women who received Avastin with chemotherapy had a 62% improvement in progression free survival (disease worsening) as compared to those who received chemotherapy alone. The Ovarian Cancer National Alliance is pleased with FDA’s action to approve Avastin and applauds the first approval of a new therapeutic in ovarian cancer since 2006. We look forward to sharing more information with the community about this decision, as it becomes available.

Raise Your Voice

Are you passionate about helping women with ovarian cancer? Do you want to make a difference for our cause? Join our 2015 Advocate Leader program to receive exclusive training and opportunities to raise your voice.

Partner Member Profile: Teal Diva

Teal Diva’s origins lie in a common need of those affected by ovarian cancer: support. When Shannon Routh was diagnosed with ovarian cancer in 2009, she also discovered that she would be unable to have children, despite her young age. For Shannon this made relating with other survivors difficult, as many of the survivors she […]

News and Events

25 Sep

Handbags for Hope

The 2015 Handbags for Hope supports the SCOCF. Read More

21 Apr

Dragon Boat Festival

2015 Upstate Dragon Boat Festival Read More

Find a Gynecologic Oncologist.


  • (first few letters is all you need)